Ardian, a private equity investment company, agreed to acquire a 70% stake in Biofarma Group, a company specializing in the development, manufacture and packaging of food supplements and medical devices, from White Bridge Investments, a private equity firm, for $1.26bn. "The nutraceutical sector is already benefitting from strong growth driven by secular trends, such as the importance attributed by customers to prevention, and Italy represents an excellence in this market recognised worldwide. Biofarma is undoubtedly the technological leader and natural consolidator of the industry, so we are very pleased to partner-up with the Group's management and the Scarpa family on this project, which will lead to an acceleration of Biofarma's growth, also at an international level,” Yann Chareton, Ardian Managing Director.